Authentidate Commends Department of Veterans Affairs

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Authentidate Commends Department of Veterans Affairs Updated Strategic Plan and Commitment to Telehealth

BERKELEY HEIGHTS, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (Nasdaq: ADAT ), a provider of secure web-based software applications and telehealth products and services for healthcare organizations, today expressed strong support for the ongoing commitment by the Department of Veterans Affairs to telehealth, as represented by the VA's recently released 2014-2020 Draft Strategic Plan . This plan reaffirms a significant commitment for telehealth, which Authentidate believes will benefit the delivery of healthcare and we commend the VA for their leadership in embracing these innovative solutions.

The VA's requested appropriation for telehealth for the 2014 fiscal year is $460 million, an increase of $19 million compared to 2013. Authentidate's telehealth solutions help healthcare providers such as the VA monitor patient health from the comfort of the patient's own home through the innovative use of technology, with the goal of improving healthcare access and patient outcomes, all while reducing the cost of care.

Ben Benjamin, Chief Executive Officer of Authentidate, stated, "The VA operates the largest integrated health care system in the country with nearly nine million enrollees. Their latest strategic plan is forward thinking and recognizes the shift towards a mobile society and the need to expand our Veteran's access to care regardless of their physical proximity to VA facilities, while continuing to be an effective steward of taxpayer dollars. Authentidate is proud to support all of these goals as an approved VA supplier of telehealth solutions."

During the last fiscal year, Authentidate worked closely with the VA on the rollout of Authentidate's telehealth solutions. Authentidate completed the required test-in phase for its device-based, Electronic House Call, and telephone based Interactive Voice Response telehealth solutions and the VA approved the use of these solutions by VA facilities throughout the country. Following the end of the fiscal year, Authentidate announced that it began to enroll patients for its sole-source VA telehealth pilot program for Human Immunodeficiency Virus (HIV) patients.

The VA's 2014-2020 Draft Strategic Plan stated, "The rapid pace of technological advancement is reshaping Veterans' expectations regarding how services, benefits, and support should be delivered … the VA will improve patient-facing and clinician-facing e-health systems by expanding the development and use of health-related virtual modalities. These modalities include telehealth."

Mr. Benjamin concluded, "The VA is a true pioneer in recognizing the positive impact that telehealth technologies such as Authentidate's can have on the cost and patient experience of healthcare delivery. The VA has a bold vision for an expanding role of telehealth, and substantial funding to implement that vision. Authentidate's mission is to play a lead role in the telehealth revolution, and we are grateful for our close partnership with the VA and the opportunity to offer tangible benefits to the Veterans who have served our country."

About Authentidate Holding Corp.

Authentidate Holding Corp. is a provider of secure web-based software applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate's products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate's telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company's healthcare customers and users include leading homecare companies, health systems, physician groups and governmental entities. These organizations utilize the company's products and services to coordinate care for patients outside of acute-care.

For more information, visit the company's website at  www.authentidate.com                                                   

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company's ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.

Authentidate and Inscrybe are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.

Media Contacts: Peter Seltzberg, Hayden IR, or (646) 415-8972 Brett Maas, Hayden IR, or (646) 536-7331

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading